Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

Symbicort was first FDA-approved in 2006 as ... a long-acting beta2-agonist bronchodilator with a fast action, in a single inhaler. A Viatris spokesperson said: "Viatris obviously disagrees ...